Document Detail


Oxidative stress and metabolism at rest and during exercise in persons with Down syndrome.
MedLine Citation:
PMID:  18277183     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Down syndrome (DS) is a risk factor for metabolic syndrome and cardiovascular disease. The greater oxidative stress described in DS can increase this risk owing to its potential deleterious effects on insulin sensitivity. We hypothesized that metabolic syndrome or its markers, at rest and during exercise, are more pronounced in young adults with DS. DESIGN: The study design is that of a controlled study. METHODS: Thirteen physically active young adults with DS, after overnight polysomnography, plasma-lipid profile, and insulin-resistance [Homeostasis Model Assessment Insulin Resistance (HOMA-IR)] assessments, underwent a submaximal progressive treadmill exercise (10 min at 30 and 50%, and 20 min at 75% of V O2max), allowing for maximal fat-oxidation rate and blood-oxidative stress determinations. They were compared with 15 healthy control participants (C). RESULTS: V O2max of DS participants was lower than that of C (60.8+/-2.4 versus 44.4+/-3.3 ml/kg/min; P<0.001) but was close to the predicted value (95+/-6%). In DS participants, as expected, oxidative stress was greater than in C (+15%; P<0.001) at rest and all through the exercise protocol. Although a greater fat mass (DS: 19.9+/-1.3%; C: 13.5+/-0.9%; P<0.001), and a lower insulin sensitivity (HOMA-IR in DS: 1.09+/-0.16; in C: 0.64+/-0.13; P<0.05) was observed for DS participants, a metabolic syndrome could not be shown. Maximal fat-oxidation rate was lower in DS participants (394.2+/-69.9 versus 486.1+/-134.8 mg/min in C; P<0.01), but it was in the normal range. CONCLUSION: Despite greater oxidative stress and lower insulin sensitivity, the DS group involved in our study did not display clear metabolic abnormalities. The young age and lifestyle of this group might, partially, have accounted for this apparently healthy metabolic status.
Authors:
Patrice Flore; Véronique-A Bricout; Debbie van Biesen; Michel Guinot; François Laporte; Jean-Louis Pépin; Yves Eberhard; Anne Favre-Juvin; Bernard Wuyam; Peter van de Vliet; Patrice Faure
Related Documents :
21484043 - Negative addiction to exercise: are there differences between genders?
19786513 - Correlates of drive for muscularity: the role of anthropometric measures and psychologi...
20086553 - Exercise rehabilitation for cardiac patients: a beneficial but underused therapy.
Publication Detail:
Type:  Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology     Volume:  15     ISSN:  1741-8267     ISO Abbreviation:  Eur J Cardiovasc Prev Rehabil     Publication Date:  2008 Feb 
Date Detail:
Created Date:  2008-02-15     Completed Date:  2008-06-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101192000     Medline TA:  Eur J Cardiovasc Prev Rehabil     Country:  England    
Other Details:
Languages:  eng     Pagination:  35-42     Citation Subset:  IM    
Affiliation:
Grenoble 1 University (Joseph Fourier) (UFRAPS and UFR Santé), IFR 1, Research on Exercise and Health Laboratory, South Hospital, Grenoble University Hospital, Grenoble cedex, France. PFlore@chu-grenoble.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Analysis of Variance
Blood Pressure Determination
Case-Control Studies
Down Syndrome / metabolism*,  physiopathology*
Exercise / physiology*
Exercise Test
Humans
Insulin Resistance
Male
Oxidative Stress*
Polysomnography
Rest

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies.
Next Document:  Exercise training decreases plasma levels of soluble CD40 ligand and P-selectin in patients with chr...